Table 6. Admission status, clinical course and outcome between ESB patients and PIB patients.
| Variable | ESB Group (n = 24) | PIB Group (n = 58) | P Value |
|---|---|---|---|
| Hemoglobin, g/L | 81.5 (73.25–99) | 91 (79.75–101.5) | NS (0.142) |
| Platelet count, ×109 cells/L | 188 (135.75–299.5) | 186 (106.75–284) | NS (0.795) |
| PT, s | 13.65 (12.8–14.75) | 13.45 (12.15–14.8) | NS (0.71) |
| APTT, s | 36.6 (31.83–42.33) | 33.5 (27.95–40.35) | NS (0.154) |
| INR | 1.2 (1.11–1.4) | 1.17 (1.055–1.2725) | NS (0.177) |
| C-reactive protein, mg/L | 125.9 (89.9–182.1) | 131.45 (96.675–191) | NS (0.744) |
| Total bilirubin, umol/L | 26.3 (15.6–83) | 24.15 (13.5–55.25) | NS (0.488) |
| Unconjugated bilirubin, umol/L | 10.9 (5.0–34.5) | 6.55 (3.55–13.075) | NS (0.06) |
| ALT, U/L | 24.5 (12.25–48.25) | 32 (21–56) | NS (0.243) |
| AST, U/L | 29 (22.5–88.5) | 34.5 (24–54.25) | NS (0.919) |
| BUN, mmol/L | 10.7 (4.8–20.6) | 9.1 (5.35–14.725) | NS (0.415) |
| Creatinine, umol/L | 207.5 (58.8–339.5) | 81.5 (49.5–188.5) | 0.037 |
| APACHE II score | 15.5 (9–22.3) | 11.5 (8.75–15) | 0.032 |
| Onset to bleeding, days | 17.5 (10–20) | 51 (26.75–70.75) | <0.001 |
| IPN, no. (%) | 19 (79.2) | 56 (96.6) | 0.010 |
| Digestive tract fistula, no. (%) | 10 (41.7) | 28 (48.3) | NS (0.585) |
| SVT, no. (%) | 5 (20.8) | 13 (22.4) | NS (0.875) |
| ACS, no. (%) | 7 (29.2) | 10 (17.2) | NS (0.225) |
| Organ failure | |||
| Shock, no. (%) | 16 (66.7) | 37 (63.8) | NS (0.804) |
| ARDS, no. (%) | 19 (79.2) | 39 (67.2) | NS (0.280) |
| AKI, no. (%) | 17 (70.8) | 34 (58.6) | NS (0.299) |
| ALI, no. (%) | 13 (54.2) | 15 (25.9) | 0.014 |
| MODS, no. (%) | 18 (75.0) | 37 (63.8) | NS (0.326) |
| Revised Atlanta classification | NS (0.230) | ||
| Mild, no. (%) | 0 (0) | 0 (0) | |
| Moderate severe, no. (%) | 2 (8.3) | 11 (19.0) | |
| Severe, no. (%) | 22 (91.7) | 47 (81.0) | |
| Mortality, no. (%) | 13 (54.2) | 18 (31.0) | 0.049 |
| Hospital duration, days | 35 (19.5–83.75) | 52 (27–78) | NS (0.343) |
| ICU duration, days | 24.5 (12.75–46.25) | 35 (18.25–53.25) | NS (0.375) |
| Cost, thousand CNY | 293 (183–459) | 416 (256–553) | NS (0.433) |
PT prothrombin time, APTT activated partial thromboplastin time, INR international normalized ratio, ALT alanine transaminase, AST aspartate transaminase, BUN blood urea nitrogen, APACHE acute physiology and chronic health evaluation, IPN infected pancreatic necrosis, SVT splanchnic venous thrombosis, ACS abdominal compartment syndrome, ARDS acute respiratory distress syndrome, AKI acute kidney injury, ALI acute liver injury, MODS multiple organ dysfunction syndrome, ICU intensive care unit. Data are expressed as median (interquartile range) for continuous variables and frequencies (proportions) for categorical variables, as appropriate. Mann–Whitney U-test and Pearson test was used as the circumstances required.